Cat.#: ACPP-1773
| Despition | LIN28 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1722 | Human SRR Protein (AC1722) | 1 µg | inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1625 | Human POMC Protein (AC1625) | 2 µg | inquiry |
| ACPP-1457 | Rat NME2 Protein (AC1457) | 5 µg | inquiry |
| ACPP-1386 | Human HMGN1 Protein (AC1386) | 2 µg | inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1281 | ULK1 Blocking Peptide (AC1281) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.